Semi-Mechanism-Based Pharmacokinetic-Toxicodynamic Model of Oxaliplatin-Induced Acute and Chronic Neuropathy
- Supplementary File 1:
ZIP-Document (ZIP, 503 KiB)
Kobuchi, S.; Shimizu, R.; Ito, Y. Semi-Mechanism-Based Pharmacokinetic-Toxicodynamic Model of Oxaliplatin-Induced Acute and Chronic Neuropathy. Pharmaceutics 2020, 12, 125. https://doi.org/10.3390/pharmaceutics12020125
Kobuchi S, Shimizu R, Ito Y. Semi-Mechanism-Based Pharmacokinetic-Toxicodynamic Model of Oxaliplatin-Induced Acute and Chronic Neuropathy. Pharmaceutics. 2020; 12(2):125. https://doi.org/10.3390/pharmaceutics12020125
Chicago/Turabian StyleKobuchi, Shinji, Risa Shimizu, and Yukako Ito. 2020. "Semi-Mechanism-Based Pharmacokinetic-Toxicodynamic Model of Oxaliplatin-Induced Acute and Chronic Neuropathy" Pharmaceutics 12, no. 2: 125. https://doi.org/10.3390/pharmaceutics12020125